{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:21:18Z","timestamp":1787062878051,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.nucmedbio.2022.108311","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T02:20:39Z","timestamp":1671848439000},"page":"108311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluation of sulfone-labeled amino acid derivatives as potential PET agents for cancer imaging"],"prefix":"10.1016","volume":"116-117","author":[{"given":"Mei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nucmedbio.2022.108311_bb0005","first-page":"624","article-title":"Likely common role of hypoxia in driving 18F-FDG uptake in cancer, myocardial ischemia, inflammation and infection","volume":"36","author":"Yao","year":"2021","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"10.1016\/j.nucmedbio.2022.108311_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/09298673113209990254","article-title":"Radiolabeled glucose derivatives for tumor imaging using SPECT and PET","volume":"21","author":"Liu","year":"2014","journal-title":"Curr Med Chem"},{"issue":"2","key":"10.1016\/j.nucmedbio.2022.108311_bb0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/RLU.0000000000000304","article-title":"Prognostic relevance of 18F-FDG PET\/CT in carcinoma of unknown primary","volume":"39","author":"Breuer","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.nucmedbio.2022.108311_bb0020","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12350-020-02424-6","article-title":"Multimodality molecular imaging: gaining insights into the mechanisms linking chronic stress to cardiovascular disease","volume":"28","author":"Osborne","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"10.1016\/j.nucmedbio.2022.108311_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11886-021-01555-7","article-title":"Acquisition, processing, and interpretation of PET 18F-FDG viability and inflammation studies","volume":"23","author":"Celiker-Guler","year":"2021","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"10.1016\/j.nucmedbio.2022.108311_bb0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/j.semnuclmed.2021.06.008","article-title":"Limitations and pitfalls of FDG-PET\/CT in infection and inflammation","volume":"51","author":"Pijl","year":"2021","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.108311_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109168","article-title":"The impact of infection and inflammation in oncologic 18F-FDG PET\/CT imaging","volume":"117","author":"Rahman","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.nucmedbio.2022.108311_bb0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41598-020-80668-5","article-title":"L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism","volume":"11","author":"Sato","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.nucmedbio.2022.108311_bb0045","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s11307-019-01456-w","article-title":"Relationship between tumor immune markers and fluorine-18-\u03b1-methyltyrosine ([18F]FAMT) uptake in patients with lung cancer","volume":"22","author":"Shimizu","year":"2020","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"10.1016\/j.nucmedbio.2022.108311_bb0050","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/ijms21051899","article-title":"Functional consequences of low activity of transport system a for neutral amino acids in human bone marrow mesenchymal stem cells","volume":"21","author":"Chiu","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.nucmedbio.2022.108311_bb0055","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.3390\/cells10113154","article-title":"Amino acid transport and metabolism regulate early embryo development: species differences, clinical significance, and evolutionary implications","volume":"10","author":"Van Winkle","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.nucmedbio.2022.108311_bb0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00726-011-0867-5","article-title":"The oxidative stress-inducible cystine\/glutamate antiporter, system x (c) (-): cystine supplier and beyond","volume":"42","author":"Conrad","year":"2012","journal-title":"Amino Acids"},{"issue":"3","key":"10.1016\/j.nucmedbio.2022.108311_bb0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2967\/jnumed.116.180661","article-title":"18F\u20135-fluoroaminosuberic acid as a potential tracer to gauge oxidative stress in breast cancer models","volume":"58","author":"Yang","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.108311_bb0070","article-title":"Glutamic acid transporters: targets for neuroprotective therapies in Parkinson's disease","volume":"15","author":"Li","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.nucmedbio.2022.108311_bb0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4939-8796-2_20","article-title":"L-[Methyl-11C]Methionine-positron-emission tomography (MET-PET)","volume":"1866","author":"Hoffman","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.nucmedbio.2022.108311_bb0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389557516666160428115446","article-title":"Development of amino acid-based radiopharmaceuticals for tumor imaging","volume":"18","author":"Zhu","year":"2018","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"10.1016\/j.nucmedbio.2022.108311_bb0085","first-page":"1144","article-title":"Synthesis of enantiopure 18F-trifluoromethyl cysteine as a structure-mimetic amino acid tracer for glioma imaging","volume":"9","author":"Liu","year":"2019"},{"issue":"23","key":"10.1016\/j.nucmedbio.2022.108311_bb0090","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3390\/cancers13236030","article-title":"Evaluation of 3-l-and 3-d-[18F]Fluorophenylalanines as PET tracers for tumor imaging","volume":"13","author":"Kr\u00e4mer","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.nucmedbio.2022.108311_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1874471009666161230114954","article-title":"Synthesis and preliminary evaluation of 5-[18F]fluoroleucine","volume":"10","author":"Chin","year":"2017","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.nucmedbio.2022.108311_bb0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fchem.2017.00124","article-title":"Carbon-11 and fluorine-18 labeled amino acid tracers for positron emission tomography imaging of tumors","volume":"5","author":"Sun","year":"2018","journal-title":"Front Chem"},{"issue":"9","key":"10.1016\/j.nucmedbio.2022.108311_bb0105","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3390\/cancers13092093","article-title":"Use of PET imaging in neuro-oncological surgery","volume":"13","author":"Holzgreve","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.nucmedbio.2022.108311_bb0110","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2967\/jnumed.112.112284","article-title":"Production at the curie level of no-carrier-added 6\u201318F-fluoro-L-dopa","volume":"54","author":"Libert","year":"2013","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2022.108311_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.canlet.2011.07.024","article-title":"Disruption of xCT inhibits cell growth via the ROS\/autophagy pathway in hepatocellular carcinoma","volume":"312","author":"Guo","year":"2011","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.nucmedbio.2022.108311_bb0120","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s00259-019-04375-8","article-title":"Influx rate of 18F-fluoroaminosuberic acid reflects cystine\/glutamate antiporter expression in tumour xenografts","volume":"46","author":"Pitman","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.nucmedbio.2022.108311_bb0125","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00259-018-4251-5","article-title":"Prospective comparison of (4S)-4-(3\u201318F-fluoropropyl)-L-glutamate versus 18F-fluorodeoxyglucose PET\/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of-concept study","volume":"46","author":"Cheng","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2022.108311_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2967\/jnumed.112.108704","article-title":"(4S)-4- (3\u201318F-fluoropropyl)-L-glutamate for imaging of XC- transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies","volume":"54","author":"Baek","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.108311_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148628","article-title":"Pilot preclinical and clinical evaluation of (4S)-4-(3- [18F]fluoropropyl)-L-glutamate (18F-FSPG) for PET\/CT imaging of intracranial malignancies","volume":"11","author":"Mittra","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.nucmedbio.2022.108311_bb0140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2967\/jnumed.113.126664","article-title":"Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid","volume":"55","author":"Webster","year":"2014","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2022.108311_bb0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13550-020-00678-2","article-title":"Initial evaluation of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate (FSPG) PET\/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma","volume":"10","author":"Park","year":"2020","journal-title":"EJNMMI Res"},{"issue":"2","key":"10.1016\/j.nucmedbio.2022.108311_bb0150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/acs.orglett.0c04054","article-title":"One-step synthesis of [18F]fluoro-4-(vinylsulfonyl)benzene: a thiol reactive synthon for selective radiofluorination of peptides","volume":"23","author":"Ma","year":"2021","journal-title":"Org Lett"},{"issue":"10","key":"10.1016\/j.nucmedbio.2022.108311_bb0155","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12149-019-01383-4","article-title":"Al18F- labeled alpha-melanocyte-stimulating hormone (\u03b1-MSH) peptide derivative for the early detection of melanoma","volume":"33","author":"Palangka","year":"2019","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.108311_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116265","article-title":"Design, synthesis and biological evaluation of novel 2,4-disubstituted quinazoline derivatives targeting H1975 cells via EGFR-PI3K signaling pathway","volume":"43","author":"Wang","year":"2021","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"10.1016\/j.nucmedbio.2022.108311_bb0165","first-page":"379","article-title":"The effects of A549 and H1299 cell-derived exosomes on the proliferation and apoptosis of BEAS-2B cells","volume":"76","author":"Li","year":"2021","journal-title":"Pharmazie"},{"issue":"9","key":"10.1016\/j.nucmedbio.2022.108311_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139089","article-title":"Dynamic FDG-PET imaging to differentiate malignancies from inflammation in subcutaneous and in situ mouse model for non-small cell lung carcinoma (NSCLC)","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2022.108311_bb0175","article-title":"18F-PEG1-vinyl sulfone-labeled red blood cells as positron emission tomography agent to image intra-abdominal bleeding","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.nucmedbio.2022.108311_bb0180","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1021\/acs.bioconjchem.0c00487","article-title":"RXH-reactive 18F-vinyl sulfones as versatile agents for PET probe construction","volume":"31","author":"Zhang","year":"2020","journal-title":"Bioconjug Chem"},{"issue":"5","key":"10.1016\/j.nucmedbio.2022.108311_bb0185","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3390\/ijms23052467","article-title":"Comparison of L- and D-amino acids for bacterial imaging in lung infection mouse model","volume":"23","author":"Muranaka","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805122023058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805122023058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:31:08Z","timestamp":1760848268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805122023058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":37,"alternative-id":["S0969805122023058"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.108311","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of sulfone-labeled amino acid derivatives as potential PET agents for cancer imaging","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.108311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108311"}}